Gold Nanoparticles for Photothermal and Photodynamic Therapy.

Cancer cells exposed to 13 nm gold nanoparticles and irradiated with cw laser light at 532 nm are shown to undergo cell death via two competing causes. When cells contain relatively high quantities of gold nanoparticles and/or receive a high dose of light, photothermal effects dominate, which are independent of the cellular location of the gold nanoparticles and affect all cells in the irradiated area due to the rapid diffusion of heat. In contrast, at lower doses of nanoparticles and light, the photogeneration of singlet oxygen triggers cell death only in cells that contain a sufficient number of nanoparticles.

Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy.

Background: The region of adipose deposition is an important determinant in the outcomes of patients with heart failure (HF). However, the impact of regional adiposity on HF patients undergoing cardiac resynchronization therapy (CRT) remains unclear.

Methods: A retrospective cohort analysis was conducted on 95 patients from a single-center study, assessing post-CRT outcomes.

Tantalum oxide nanoparticles as versatile and high-resolution X-ray contrast agent for intraductal image-guided ablative procedure in rodent models of breast cancer.

There are limited options for primary prevention of breast cancer (BC). Experimental procedures to locally prevent BC have shown therapeutic efficacy in animal models. To determine the suitability of FDA-approved iodine-containing and various metal-containing (bismuth, gold, iodine, or tantalum) preclinical nanoparticle-based contrast agents for image-guided intraductal (ID) ablative treatment of BC in rodent models, we performed a prospective longitudinal study to determine the imaging performance, local retention and systemic clearance, safety profile, and compatibility with ablative solution of each contrast agent.